The potential neuroprotective effects of cannabinoids against paclitaxel-induced peripheral neuropathy: in vitro study on neurite outgrowth
Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a shared burden for 68.1% of oncological patients undergoing chemotherapy with Paclitaxel (PTX). The symptoms are intense and troublesome, patients reporting paresthesia, loss of sensation, and dysesthetic pain. While current medicat...
Saved in:
Main Authors: | Ioana Creanga-Murariu (Author), Leontina-Elena Filipiuc (Author), Maria-Raluca Gogu (Author), Mitica Ciorpac (Author), Carmen Marinela Cumpat (Author), Bogdan-Ionel Tamba (Author), Teodora Alexa-Stratulat (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Should oncologists trust cannabinoids?
by: Ioana Creanga-Murariu, et al.
Published: (2023) -
Preliminary Insights into JWH182: a Synthetic Cannabinoid's Neuroprotective Role Against Paclitaxel-Induced Neuronal Toxicity
by: Mălina Maria Cernătescu, et al.
Published: (2023) -
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
by: Leontina Elena Filipiuc, et al.
Published: (2021) -
The Skin and Natural Cannabinoids-Topical and Transdermal Applications
by: Silviu-Iulian Filipiuc, et al.
Published: (2023) -
Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified <i>Cannabis sativa</i> L. in Rodents
by: Leontina-Elena Filipiuc, et al.
Published: (2023)